Sign In
Buy ANIP
$75.23
+0.580 (+0.777%)
At Close: Jun 03, 2026
Why ANI Pharmaceuticals (ANIP) is a Top Growth Stock for the Long-Term
10:46am, Friday, 29'th May 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference
06:50am, Wednesday, 27'th May 2026
PRINCETON, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that Nikhil Lalwani, Chief Executive Officer, will participate in a fire
ANI Pharmaceuticals: Rare Disease Shift and the 2026 Playbook
12:51pm, Friday, 15'th May 2026
ANIP leans into rare disease growth as Cortrophin and Iluvien drive specialty momentum, while 2026 focuses on retina recovery and launch cadence.
ANIP Valuation: Does 9.8x Forward P/E Offer Upside?
12:47pm, Friday, 15'th May 2026
ANI Pharmaceuticals trades at 9.83x forward earnings, far below peers and its five-year median despite rising Rare Disease sales.
ANIP Stock: What's Driving Cortrophin Gel's 2026 Surge
12:40pm, Friday, 15'th May 2026
Cortrophin Gel is reshaping ANI Pharmaceuticals into a specialty-driven growth story, with 2026 revenue guidance signaling another major leap.
ANI Pharmaceuticals (ANIP) is a Top-Ranked Momentum Stock: Should You Buy?
10:51am, Wednesday, 13'th May 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Global Alpha Dumps 229,000 Ani Pharmaceuticals (ANIP) Shares Worth $17.9 Million
05:09pm, Monday, 11'th May 2026
ANI Pharmaceuticals develops and manufactures branded and generic drugs for diverse North American healthcare markets.
ANIP Q1 Earnings & Sales Beat Estimates, '26 Outlook Raised
12:31pm, Monday, 11'th May 2026
ANI Pharmaceuticals tops Q1 estimates as Cortrophin Gel sales climb 42%, prompting it to raise the 2026 revenue, EBITDA and EPS outlook.
ANI Pharmaceuticals Q1 Earnings Call Highlights
04:07pm, Friday, 08'th May 2026
ANI Pharmaceuticals NASDAQ: ANIP reported first-quarter 2026 results that management said show continued progress in its effort to “accelerat[e] our transformation into a leading rare disease compan
ANI Pharmaceuticals, Inc. (ANIP) Q1 2026 Earnings Call Transcript
12:51pm, Friday, 08'th May 2026
ANI Pharmaceuticals, Inc. (ANIP) Q1 2026 Earnings Call Transcript
ANI (ANIP) Reports Q1 Earnings: What Key Metrics Have to Say
10:31am, Friday, 08'th May 2026
The headline numbers for ANI (ANIP) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates an
ANI Pharmaceuticals (ANIP) Tops Q1 Earnings and Revenue Estimates
09:05am, Friday, 08'th May 2026
ANI Pharmaceuticals (ANIP) came out with quarterly earnings of $2.05 per share, beating the Zacks Consensus Estimate of $1.28 per share. This compares to earnings of $1.7 per share a year ago.
ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance
06:50am, Friday, 08'th May 2026
PRINCETON, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced financial results and business highlights for the first quarter ended Ma
ANI Pharmaceuticals (ANIP) is a Top-Ranked Growth Stock: Should You Buy?
10:45am, Wednesday, 06'th May 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Are These 5 Biotech Stocks Set to Beat Q1 Earnings Estimates?
10:56am, Monday, 04'th May 2026
ANI Pharmaceuticals, Novavax and three other biotechs show strong Earnings ESP signals, hinting at potential Q1 earnings beat as sector results roll in.
